Paul Berggreen’s Post

On the one hand, it's appalling that healthcare (in practice) is just discovering the importance of signal-to-noise ratios; on the other hand, at least a few organizations *are* starting to work on it. I often use this case study, which includes that problem (and more), in my teaching: https://lnkd.in/gTgqjrfT

"SNOMED CT is perceived as a valuable tool for use in clinical practice as it represents language used by clinicians.... Clinicians will be able to record patient information in an unambiguous and homogenous way." I would have to caveat this quote a bit. Clinicians will not be using SNOMED codes off the bat... They're too complicated to look up and type out. Instead it'll require auto-coding and clinical coders to the review the annotations. Other than those matters - which are already solved both technically and organisationally with not much investment - SNOMED is a data requirement for full semantic interoperability and a much improved clinical value chain. It also stands to actually hugely reduce the cost of clinical data management because it cleans data at source, which benefits everyone, especially in patien safety. It's also far less costly that pushing unstructured data to a data warehouse (away from the clinicians and clinical coders) and hoping an ML AI will be able read what it's looking at accurately. I often say now, we pay several times to never get our health data. With SNOMED, that problem is much reduced, but it requires a mindset change across the health system.

BP + Better positioning = Better Clinical Outcomes. 

What IS the best way to be sure that #doctors keep up on the latest developments in their field? Maybe monthly updates plus a mandatory end of year summary of new findings and practices? Changes in clinical practice to assure that digital searches for information and increased collaboration become more routine? The debate over testing continues, with many MDs arguing that the tests now in use do not protect #patients, are an unreasonable burden for doctors, and serve only to enrich a #medical bureaucracy: https://lnkd.in/esbC2iNd

Every day, millions of patients have their #BloodPressure (BP) taken. But a recent study conducted by The OSU Department of Family and Community Medicine proves that something as seemingly minor as the patient's position during BP capture can have a significant impact on the measurement and thus, the clinical decision. The more #healthcare workers understand the results of this study, the more effective care they can provide for patients. Read more. https://ow.ly/f31B50QzfV4 #VitalSigns #Vitals #ClinicalCare

Twenty-five years ago, as a young academic internist, I came across a piece of technology that changed the trajectory of my life! The first handheld monitor that measures anticoagulation (blood thinner) like diabetics measure blood sugar. With 2 monitors, a nurse and I managed a few hundred patients who no longer had to go to the lab for testing, or play phone tag with their doctors for results. It was a huge success, enhancing clinical outcomes, patient and provider satisfaction, and decreasing cost. I witnessed firsthand the impact of technology on patient care, influencing me to dedicate my career to these types of projects. Over the next 20 years, my journey involved developing a methodology to scale technology solutions within complex healthcare systems despite challenges such as regulation, system complexity, and reimbursement issues. I called it Value-Based Medical Technology Solution (VBMTS) Design. A year ago, I started NewHealthcare Platforms to partner with best-in-class medical technology companies to create value-based solutions that change lives at scale! My first partner is iRhythm which monitoring technology I selected as CMO, Health Plan to expand our ability to diagnose arrhythmia. When I first started doing this work, I had to rely on clinical studies to evaluate technology. I was always uneasy because clinical studies have strictly controlled environments that are different from real world care. Today with advances in EHRs and advanced analytics, massive data sets of healthcare delivery and outcomes, called Real World Evidence (RWE), are available to evaluate medical technology! A recent RWE study of the entire Medicare data set validated that iRhythm's technology stands as best-in-class in diagnosing arrhythmias, a condition that affects millions and leads to severe complications like stroke and heart failure. The study confirmed not just the clinical benefits but also the cost savings associated with using advanced monitoring technologies with iRhythm’s Zio monitor being the most effective, significantly outperformed traditional monitoring methods in diagnosing arrhythmias among Medicare beneficiaries without prior arrhythmia diagnoses. It achieved the highest odds of diagnosis with the lowest odds of retesting, and the lowest healthcare expenditures. I couldn’t be happier with my career choice or more grateful for the opportunity to partner with companies like iRhythm! ___________________________________________ Dr. Sam Basta is a pioneer of Value-Based Care Platforms with two decades experience leading award-winning care delivery transformation at payer and provider organizations. His company, NewHealthcare Platforms, provides consulting services to the Medical Device industry specializing in value-based solution design and go-to-market execution. His thought leadership articles and weekly newsletter are widely followed (25,000+) gaining LinkedIn Top Voice recognition. #healthcareonlinkedin

Physicians and surgeons not adhering to clinical practice guidelines regarding antimicrobial usage can be attributed to several factors. Let's explore some of these barriers: 1. Awareness: Lack of awareness about the existence or specifics of guidelines can hinder adherence. Physicians may not be familiar with the latest recommendations, leading to deviations from best practices. 2. Familiarity: Even if physicians are aware of guidelines, they might not be familiar with the details. Familiarity with specific recommendations is crucial for consistent implementation. 3. Agreement: Some physicians may not agree with certain guidelines due to conflicting evidence or personal beliefs. Disagreement can lead to non-compliance. 4. Self-Efficacy: Confidence in applying guidelines effectively plays a role. If physicians doubt their ability to follow recommendations, they may deviate from them. 5. Outcome Expectancy: Anticipated outcomes influence behavior. If physicians perceive little benefit from adhering to guidelines, they may choose alternative approaches. 6. Inertia of Previous Practice: Breaking away from established habits can be challenging. Physicians may continue their existing practices even when guidelines suggest otherwise. 7. External Barriers: Practical obstacles, such as lack of resources or time constraints, can hinder adherence. Physicians may find it difficult to implement recommendations due to external factors. Understanding these barriers can guide the development of effective interventions to improve guideline adherence and enhance patient care. Source: Conversation with Bing, 3/18/2024 (1) Why Don’t Physicians Follow Clinical Practice Guidelines?. https://lnkd.in/dXWbySzD. (2) Why Don't Physicians Follow Clinical Practice Guidelines?. https://lnkd.in/dw6ChEpT. (3) Why doctors sometimes don't follow guidelines - Advisory. https://lnkd.in/dCYAQNrW. (4) What should prescribers do? | Information for the public ... - NICE. https://lnkd.in/dNEvdHaE. #antimicrobialstewardship #antimicrobialresistance

GI doctors are required to collaborate with primary care physicians. Thus, it is expected that clinicians effectively share medical records, especially in light of communicating existing medical conditions and therapy attempts for the complaints at hand. Learn how the Gastroenterology specialty is adopting new technologies to enable patient care: https://hubs.ly/Q02s93770

Jean-Luc Tilly, from The Leapfrog Group, emphasizes two crucial points in response to the JAMA Internal Medicine study on diagnostic errors in this recent article from Medical Economics. First, he notes that hospitals with limited access to specialists and delays in testing—common in non-academic medical centers—likely experience higher rates of diagnostic errors, suggesting a broader national challenge. Second, Tilly underscores that addressing diagnostic errors transcends individual clinician responsibility, highlighting the role of hospital leadership and the healthcare system in prioritizing and providing the necessary resources for accurate diagnostics. At Atalan, we echo Tilly's call to action by offering a solution that bridges the gap in access to specialized diagnostics, supporting healthcare leaders in their mission to elevate patient care and safety. Our network connects health systems to a broad array of specialized labs, ensuring timely and precise diagnostics, critical to overcoming the challenges outlined by Tilly. Follow the link below to read his full response. #PatientSafety #DiagnosticAccuracy #HealthcareLeadership #Atalan